Zdrowie i gospodarka · 11/06/1998
FDA Grants Special Termination to Dr. Dulal C. Chatterji
The FDA has lifted Dr. Dulal C. Chatterji's debarment, citing his substantial assistance in investigations and prosecutions related to FDA jurisdiction, and that this move serves the interest of justice without compromising the drug approval process.